Combined use of subclinical hydroxyurea and CHK1 inhibitor effectively controls melanoma and lung cancer progression, with reduced normal tissue toxicity compared to gemcitabine
Zay Yar Oo(Translational Research Institute), Brian Gabrielli(Mater Research)
Cited by 24
Related Papers
MAPK Pathway Activation Delays G2/M Progression by Destabilizing Cdc25B
|Journal of Biological Chemistry|2009|36
CDC25B Overexpression Stabilises Centrin 2 and Promotes the Formation of Excess Centriolar Foci
|PLoS ONE|2013|27
Mechanism of action of the third generation benzopyrans and evaluation of their broad anti-cancer activity in vitro and in vivo
|Scientific Reports|2018|16
Aurora B inhibitors promote RB hypophosphorylation and senescence independent of p53-dependent CDK2/4 inhibition
|Cell Death and Disease|2024|11